Electra Therapeutics Earnings
NASDAQ: ETRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
8.11-0.83 (-9.28%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Electra Therapeutics earnings summary
In its most recent report on Nov 12, 2026 (Sep/2026), ETRA posted EPS of $-3.47 versus the $-1.76 consensus estimate, a negative surprise of 97.2%.
Summary generated from market data by MetaCap's automated system. Methodology
ETRA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 12, 2026 | $-1.76 | $-3.47 | -97.2% | -8.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.